EnerG2 aims to improve ultracapacitors for electric cars, industry

EnerG2 aims to improve ultracapacitors for electric cars, industry

EnerG2 Inc., an ultracapacitor startup that has kept quiet until now, is launching today with the official announcement that it has raised $8.5 million in its first round of financing. Founded in 2003, it has spent five years developing electrode materials that it claims can boost… Continue Reading

Life-science briefing: Friday, March 14, 2008

Life-science briefing: Friday, March 14, 2008

TODAY’S HEADLINES

Cantimer takes in $2M for dehydration diagnostics (VentureWire)
Recodagen launches, takes aim at cancer (release)
Juniper Diagnostics spins out of ChemSensing (VentureWire)

Cantimer takes in $2M for dehydration diagnostics –The mystery of Menlo Park, Calif.-based Cantimer has resolved a bit. We wrote about this stealthy company back… Continue Reading

Alder Bio and its yeast-produced antibodies take in $40M

Alder Bio and its yeast-produced antibodies take in $40M

Alder Biopharmaceuticals, a Bothell, Wash., developer of antibody drugs, raised $40 million in a third funding round. Investors included Delphi Ventures, TPG Biotech, Sevin Rosen Funds, Ventures West, H.I.G. Ventures, and WRF Capital.

Alder develops antibody-based drugs for inflammation and autoimmune disease. The company’s lead candidate,… Continue Reading

Life sciences briefing: Wednesday, Sept. 26, 2007

Life sciences briefing: Wednesday, Sept. 26, 2007

Featured companies: Ablynx, Cardiosolutions, Carigent Thereapeutics, Elusys, Genome Corp., GlobeImmune, Novazone, Targanta Therapeutics, Waterfront Media

UPDATED at 5:45am on 9/27/07

GlobeImmune raises $41M for immune-system therapies — GlobeImmune, a Louisville, Colo., biotech focused on new forms of immunotherapy to treat viral infections and cancer, raised $41.2 million in… Continue Reading

Life sciences briefing: Wednesday, Sept. 5, 2007

Life sciences briefing: Wednesday, Sept. 5, 2007

Featured companies: Atritech, Avalon Partners, Ensemble Discovery, Hyperion Therapeutics, LifeBond, ReShape Medical, SafeStitch, Trophos, UltraShape

Hyperion Therapeutics raises $40M against GI and kidney disease — Hyperion Therapeutics, a South San Francisco, Calif., specialty pharmaceutical company, raised $40 million in a second funding round. Investors included Sofinnova Ventures,… Continue Reading

Farecast, the airfare prediction site, raises $12.1M more

Farecast, the airfare prediction site, raises $12.1M more

Farecast.com, the young Seattle start-up that now owns the niche of predicting airfares, and which continues to roll out new features (like letting you guarantee low fares), has raised $12.1 million more.

The round was led by Sutter Hill Ventures, and includes PAR Capital Management, Pinnacle… Continue Reading